PA8525201A1 - Tetrazolil-fenil acetamidas como activadores de la glucoquinasa - Google Patents
Tetrazolil-fenil acetamidas como activadores de la glucoquinasaInfo
- Publication number
- PA8525201A1 PA8525201A1 PA20018525201A PA8525201A PA8525201A1 PA 8525201 A1 PA8525201 A1 PA 8525201A1 PA 20018525201 A PA20018525201 A PA 20018525201A PA 8525201 A PA8525201 A PA 8525201A PA 8525201 A1 PA8525201 A1 PA 8525201A1
- Authority
- PA
- Panama
- Prior art keywords
- tetrazolil
- activators
- glucoquinase
- acetamidas
- fenil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22549400P | 2000-08-15 | 2000-08-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8525201A1 true PA8525201A1 (es) | 2002-07-30 |
Family
ID=22845106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20018525201A PA8525201A1 (es) | 2000-08-15 | 2001-08-14 | Tetrazolil-fenil acetamidas como activadores de la glucoquinasa |
Country Status (20)
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US7078423B2 (en) * | 2002-07-18 | 2006-07-18 | Inotek Pharmaceuticals Corporation | 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
US7087631B2 (en) * | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
CA2498089A1 (en) * | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
PE20040801A1 (es) | 2002-12-12 | 2004-11-25 | Hoffmann La Roche | Derivados de pirazina y piridina 5-sustituidos como activadores de glucoquinasa |
AU2003294376A1 (en) * | 2003-01-06 | 2004-08-10 | Eli Lilly And Company | Heteroaryl compounds |
JP4621198B2 (ja) * | 2003-02-11 | 2011-01-26 | プロシディオン・リミテッド | トリ(シクロ)置換アミドグルコキナーゼ活性化化合物 |
PL378117A1 (pl) * | 2003-02-11 | 2006-03-06 | Prosidion Limited | Tricyklopodstawione związki amidowe |
MXPA06011365A (es) | 2004-04-02 | 2006-12-15 | Novartis Ag | Derivados de tiazolo-piridina, composiciones farmaceuticas que los contienen, y metodos para el tratamiento de condiciones mediadas por glucoquinasa. |
AU2005229416B2 (en) | 2004-04-02 | 2009-03-26 | Novartis Ag | Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful the treatment of type 2 diabetes |
CN101218237B (zh) | 2005-07-11 | 2012-03-28 | 田边三菱制药株式会社 | 肟衍生物及其制备方法 |
BRPI0615236A2 (pt) | 2005-08-31 | 2011-05-10 | Astellas Pharma Inc | derivado de tiazol |
JP2007063225A (ja) * | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
KR20080048504A (ko) | 2005-09-29 | 2008-06-02 | 사노피-아벤티스 | 페닐- 및 피리디닐-1,2,4-옥사디아졸론 유도체, 이의제조방법 및 약제로서의 이의 용도 |
GT200600428A (es) | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
GT200600429A (es) | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
CA2626475A1 (en) * | 2005-11-03 | 2007-05-10 | Prosidion Limited | Tricyclo substituted amides |
JP2009515997A (ja) * | 2005-11-18 | 2009-04-16 | タケダ サン ディエゴ インコーポレイテッド | グルコキナーゼ活性剤 |
BRPI0619980A2 (pt) * | 2005-12-15 | 2014-10-14 | Nihon Nohyaku Co Ltd | Derivados de ftalamida e de anilina, inseticida agrícola ou hortícula, e, método de uso do mesmo |
WO2007104034A2 (en) | 2006-03-08 | 2007-09-13 | Takeda San Diego, Inc. | Glucokinase activators |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
ATE522518T1 (de) * | 2006-05-31 | 2011-09-15 | Takeda San Diego Inc | Indazol- und isoindolderivate als glucokinaseaktivierende stoffe |
US7910747B2 (en) * | 2006-07-06 | 2011-03-22 | Bristol-Myers Squibb Company | Phosphonate and phosphinate pyrazolylamide glucokinase activators |
US7902248B2 (en) | 2006-12-14 | 2011-03-08 | Hoffmann-La Roche Inc. | Oxime glucokinase activators |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
TW200831081A (en) * | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
US8314247B2 (en) * | 2007-01-10 | 2012-11-20 | Mitsubishi Tanabe Pharma Corporation | Hydrazone derivative |
JP5248477B2 (ja) | 2007-03-07 | 2013-07-31 | 杏林製薬株式会社 | グルコキナーゼ活性化物質 |
US8173645B2 (en) * | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
JP5580201B2 (ja) * | 2007-10-08 | 2014-08-27 | アドビヌス・セラピューティクス・プライベート・リミテッド | グルコキナーゼアクチベータとしてのアセトアミド誘導体、その製法及び医薬応用 |
TW200934772A (en) * | 2008-01-15 | 2009-08-16 | Lilly Co Eli | Crystalline(R)-2-(4-cyclopropanesulphonyl-phenyl)-N-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
CN101918363B (zh) | 2008-01-18 | 2012-09-05 | 安斯泰来制药株式会社 | 苯乙酰胺衍生物 |
ES2542753T3 (es) | 2008-04-28 | 2015-08-10 | Kyorin Pharmaceutical Co., Ltd. | Derivado de ciclopentilacrilamida |
EP3199623B1 (en) | 2010-03-31 | 2021-07-28 | The Scripps Research Institute | Reprogramming cells |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3776917A (en) * | 1972-06-05 | 1973-12-04 | Schering Corp | 2-amino-6-phenalkyl-aminopyridines and derivatives thereof |
GB8909574D0 (en) | 1989-04-26 | 1989-06-14 | Ici Plc | Chemical process |
US5859052A (en) * | 1993-01-14 | 1999-01-12 | G. D. Searle & Co. | Fatty acid analogs and prodrugs |
US5468867A (en) * | 1994-05-27 | 1995-11-21 | Syntex (U.S.A.) Inc. | Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid |
US5461049A (en) * | 1994-05-27 | 1995-10-24 | Warner-Lambert Company | Amide tetrazole ACAT inhibitors |
TR199902442T2 (xx) * | 1997-01-28 | 2000-07-21 | Merck & Co.,Inc. | �eker ve �i�manl�k tedavisinde �3 agonistleri olarak tiazol benzens�lfonamidler. |
SI1169312T1 (en) * | 1999-03-29 | 2005-02-28 | F. Hoffmann-La Roche Ag | Glucokinase activators |
-
2001
- 2001-08-08 US US09/924,247 patent/US6369232B1/en not_active Expired - Fee Related
- 2001-08-09 CA CA002419416A patent/CA2419416C/en not_active Expired - Fee Related
- 2001-08-09 KR KR10-2003-7002231A patent/KR100518061B1/ko not_active IP Right Cessation
- 2001-08-09 WO PCT/EP2001/009207 patent/WO2002014312A1/en active IP Right Grant
- 2001-08-09 EP EP01962926A patent/EP1311504B1/en not_active Expired - Lifetime
- 2001-08-09 AU AU8399801A patent/AU8399801A/xx active Pending
- 2001-08-09 AT AT01962926T patent/ATE297921T1/de not_active IP Right Cessation
- 2001-08-09 CN CNB018163475A patent/CN1209362C/zh not_active Expired - Fee Related
- 2001-08-09 AU AU2001283998A patent/AU2001283998B2/en not_active Ceased
- 2001-08-09 ES ES01962926T patent/ES2243541T3/es not_active Expired - Lifetime
- 2001-08-09 JP JP2002519452A patent/JP3961948B2/ja not_active Expired - Fee Related
- 2001-08-09 DE DE60111540T patent/DE60111540T2/de not_active Expired - Lifetime
- 2001-08-09 DK DK01962926T patent/DK1311504T3/da active
- 2001-08-09 MX MXPA03001275A patent/MXPA03001275A/es active IP Right Grant
- 2001-08-09 BR BR0113312-8A patent/BR0113312A/pt not_active IP Right Cessation
- 2001-08-09 PT PT01962926T patent/PT1311504E/pt unknown
- 2001-08-14 AR ARP010103886A patent/AR031718A1/es active IP Right Grant
- 2001-08-14 PA PA20018525201A patent/PA8525201A1/es unknown
- 2001-08-14 UY UY26885A patent/UY26885A1/es not_active Application Discontinuation
- 2001-08-15 PE PE2001000814A patent/PE20020386A1/es not_active Application Discontinuation
- 2001-10-11 US US09/975,713 patent/US6388088B1/en not_active Expired - Fee Related
-
2002
- 2002-01-16 US US10/050,508 patent/US6441180B1/en not_active Expired - Fee Related
-
2003
- 2003-01-31 ZA ZA200300904A patent/ZA200300904B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE60111540D1 (de) | 2005-07-21 |
DE60111540T2 (de) | 2006-03-16 |
US20020065275A1 (en) | 2002-05-30 |
AU8399801A (en) | 2002-02-25 |
PT1311504E (pt) | 2005-10-31 |
CN1466584A (zh) | 2004-01-07 |
DK1311504T3 (da) | 2005-10-17 |
CA2419416C (en) | 2009-10-13 |
US20020035266A1 (en) | 2002-03-21 |
CA2419416A1 (en) | 2002-02-21 |
PE20020386A1 (es) | 2002-05-13 |
ATE297921T1 (de) | 2005-07-15 |
JP2004506632A (ja) | 2004-03-04 |
AR031718A1 (es) | 2003-10-01 |
BR0113312A (pt) | 2003-07-01 |
ES2243541T3 (es) | 2005-12-01 |
US6369232B1 (en) | 2002-04-09 |
AU2001283998B2 (en) | 2005-10-20 |
KR100518061B1 (ko) | 2005-09-28 |
MXPA03001275A (es) | 2003-06-30 |
EP1311504A1 (en) | 2003-05-21 |
ZA200300904B (en) | 2004-04-30 |
JP3961948B2 (ja) | 2007-08-22 |
CN1209362C (zh) | 2005-07-06 |
US6441180B1 (en) | 2002-08-27 |
US6388088B1 (en) | 2002-05-14 |
KR20030022408A (ko) | 2003-03-15 |
UY26885A1 (es) | 2002-02-28 |
EP1311504B1 (en) | 2005-06-15 |
US20020035267A1 (en) | 2002-03-21 |
WO2002014312A1 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8525201A1 (es) | Tetrazolil-fenil acetamidas como activadores de la glucoquinasa | |
ECSP014054A (es) | Activadores de glucoquinasa alquinil fenil heteroaromatica | |
ECSP014055A (es) | Activadores de glucoquinasa que contienen hidantoina | |
UY26694A1 (es) | Activadores de fenil glucocinasa para - arilo o hetero sustituidos | |
PA8534601A1 (es) | Activadores de glucocinasa del tipo isoindolin-1-ona | |
PA8584001A1 (es) | Indol-3-carboxamidas como activadores de glucoquinasa (gk) | |
CR20110477A (es) | Inhibidores de enzimas de proteina cinasa activadas por mitogeno p38 | |
PA8600601A1 (es) | Ligandos de receptores de cannabinoides y sus usos | |
UY29249A1 (es) | Agentes citotóxicos que comprenden taxanos nuevos | |
ATE531382T1 (de) | Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen | |
DOP2006000052A (es) | Alargar el tiempo hasta la progresión de la enfermedad o la supervivencia de los pacientes de cáncer | |
CL2008001197A1 (es) | Compuestos derivados de amidas sustituidas, moduladoras de la actividad de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome metabolico, resistencia a la insulina, dislipidemia, entre otras. | |
ECSP105178A (es) | Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos | |
CR20110230A (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
ATE494280T1 (de) | Stereoisomerisch angereicherte 3-aminocarbonyl- bicyclohepten-pyrimidindiamin-verbindungen und ihre verwendungen | |
EA201170651A1 (ru) | Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин | |
UY28731A1 (es) | Compuestos quimicos | |
UY29250A1 (es) | Agentes citotóxicos que comprenden nuevos taxanos modificados en c-2.- | |
NI201000015A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
TR201901390T4 (tr) | Demodikoza karşı madde. | |
UY28313A1 (es) | Nonadepsipeptidos acilados | |
UY29189A1 (es) | Nonadepsipeptidos acilados ii | |
ATE534649T1 (de) | Imidazothiazole und imidazoxazolderivative als inhibitoren von p38 | |
BRPI0511125A (pt) | usos de ácido 5,6,7-triidroxieptanóico seus e análogos | |
GB0326633D0 (en) | Therapeutic agents |